GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 220 filers reported holding GENOMIC HEALTH INC in Q3 2019. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,903,000 | -26.8% | 57,540 | -37.2% | 0.00% | -20.0% |
| Q2 2019 | $5,333,000 | -10.9% | 91,681 | +7.3% | 0.01% | -16.7% |
| Q1 2019 | $5,984,000 | +53.2% | 85,427 | +40.9% | 0.01% | +50.0% |
| Q4 2018 | $3,905,000 | -24.8% | 60,625 | -18.0% | 0.00% | -20.0% |
| Q3 2018 | $5,191,000 | +37.6% | 73,920 | -1.2% | 0.01% | +25.0% |
| Q2 2018 | $3,772,000 | +55.5% | 74,840 | -3.5% | 0.00% | +100.0% |
| Q1 2018 | $2,425,000 | -6.3% | 77,515 | +2.4% | 0.00% | 0.0% |
| Q4 2017 | $2,588,000 | +358.1% | 75,675 | +287.3% | 0.00% | +100.0% |
| Q3 2016 | $565,000 | -11.2% | 19,540 | -20.4% | 0.00% | 0.0% |
| Q2 2016 | $636,000 | +78.2% | 24,560 | +70.6% | 0.00% | – |
| Q1 2016 | $357,000 | -61.4% | 14,400 | -50.7% | 0.00% | -100.0% |
| Q2 2013 | $926,000 | – | 29,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 11,744,010 | $756,432,000 | 6.19% |
| EMORY UNIVERSITY | 30,319 | $1,953,000 | 1.54% |
| Copper Rock Capital Partners, LLC | 292,596 | $18,630,000 | 1.46% |
| DE BURLO GROUP INC | 73,600 | $4,740,000 | 1.06% |
| Eversept Partners, LP | 23,866 | $1,537,209 | 0.83% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 165,310 | $10,648,000 | 0.83% |
| Aurora Investment Counsel | 20,916 | $1,347,000 | 0.73% |
| Texas Children's | 8,035 | $518,000 | 0.72% |
| Capital Impact Advisors, LLC | 24,665 | $1,570,000 | 0.67% |
| Granahan Investment Management | 130,650 | $8,415,000 | 0.60% |